✦ LIBER ✦

Is there any predictor for clinical outcome in EGFR mutant NSCLC patients treated with EGFR TKIs?

✍ Scribed by Lee, Ji Yun; Lim, Sung Hee; Kim, Moonjin; Kim, Sungmin; Jung, Hyun Ae; Chang, Won Jin; Choi, Moon Ki; Hong, Jung Yong; Lee, Su Jin; Sun, Jong-Mu; Ahn, Jin Seok; Park, Keunchil; Ahn, Myung-Ju

Book ID: 125344291
Publisher: Springer
Year: 2014
Tongue: English
Weight: 258 KB
Volume: 73
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-014-2442-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9154 Clinical outcomes in patients with

9154 Clinical outcomes in patients with EGFR mutations: pooled analysis of NSCLC patients treated with either an EGFR TKI or chemotherapy

✍ Paz-Ares, L.; Soulières, D.; Klughammer, B.; Melezínek, I.; Moecks, J.; Keil, L. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB

EGFR CA repeat polymorphism predict clin

EGFR CA repeat polymorphism predict clinical outcome in EGFR mutation positive NSCLC patients treated with erlotinib

✍ Winther Larsen, Anne; Nissen, Peter Henrik; Meldgaard, Peter; Weber, Britta; Sor 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 695 KB

414 Correlation of mutations in EGFR wit

414 Correlation of mutations in EGFR with clinical outcomes in NSCLC patients treated with erlotinib

✍ D. Eberhard; L. Amler; A. Goddard; W. Ince; T. Januario; K. Hillan; M. Ostland; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Impact of specific mutant KRAS on clinic

Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype

✍ Metro, Giulio; Chiari, Rita; Duranti, Simona; Siggillino, Annamaria; Fischer, Ma 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 568 KB

CYP1A1*2A polymorphism as a predictor of

CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphism

✍ Qiang Nie; Xue-ning Yang; She-juan An; Xu-chao Zhang; Jin-ji Yang; Wen-zhao Zhon 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 289 KB

The Impact of EGFR T790M Mutations and B

The Impact of EGFR T790M Mutations and BIM mRNA Expression on Outcome in Patients with EGFR-Mutant NSCLC Treated with Erlotinib or Chemotherapy in the Randomized Phase III EURTAC Trial

✍ Costa, C.; Molina, M. A.; Drozdowskyj, A.; Gimenez-Capitan, A.; Bertran-Alamillo 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 651 KB